Front. Pharmacol. Frontiers in Pharmacology Front. Pharmacol. 1663-9812 Frontiers Media S.A. 1073679 10.3389/fphar.2022.1073679 Pharmacology Correction Corrigendum: Exploiting curcumin synergy with natural products using quantitative analysis of dose-effect relationships in an experimental in vitro model of osteoarthritis D’Ascola et al. 10.3389/fphar.2022.1073679 D’Ascola Angela 1 † Irrera Natasha 1 † Ettari Roberta 2 Bitto Alessandra 1 Pallio Giovanni 1 Mannino Federica 1 Atteritano Marco 1 Campo Giuseppe M. 1 Minutoli Letteria 1 Arcoraci Vincenzo 1 Squadrito Violetta 1 Picciolo Giacomo 1 Squadrito Francesco 1 * Altavilla Domenica 3 1 Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy 2 Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Messina, Italy 3 Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina, Italy

Approved by: Frontiers Editorial Office Frontiers Media SA, Switzerland

 *Correspondence: Francesco Squadrito, fsquadrito@unime.it

†These authors have contributed equally to this work

This article was submitted to Ethnopharmacology, a section of the journal Frontiers in Pharmacology

 07 11 2022 2022 13 1073679 18 10 2022 19 10 2022 Copyright © 2022 D’Ascola, Irrera, Ettari, Bitto, Pallio, Mannino, Atteritano, Campo, Minutoli, Arcoraci, Squadrito, Picciolo, Squadrito and Altavilla. 2022 D’Ascola, Irrera, Ettari, Bitto, Pallio, Mannino, Atteritano, Campo, Minutoli, Arcoraci, Squadrito, Picciolo, Squadrito and Altavilla

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 A Corrigendum on Exploiting curcumin synergy with natural products using quantitative analysis of dose-effect relationships in an experimental in vitro model of osteoarthritis by D’Ascola A, Irrera N, Ettari R, Bitto A, Pallio G, Mannino F, Atteritano M, Campo GM, Minutoli L, Arcoraci V, Squadrito V, Picciolo G, Squadrito F and Altavilla D (2019). Front. Pharmacol. 10:01347. doi: 10.3389/fphar.2019.01347 synergy curcumin flavocoxid beta-caryophyllene inflammation

In the published article, the Conflict of Interest statement was incorrectly filed. The correct Conflict of Interest statement appears below.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Conflict of Interest

Author DA is co-inventor on a patent related to curcumin synergy in anti-inflammatory formulations. Author FS has received research support from Primus Pharmaceuticals for work on genistein.

The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

 Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.